HomeCompareDNVVF vs EPRT

DNVVF vs EPRT: Dividend Comparison 2026

DNVVF yields 400.00% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DNVVF wins by $11437.76M in total portfolio value
10 years
DNVVF
DNVVF
● Live price
400.00%
Share price
$0.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11437.82M
Annual income
$7,667,192,697.76
Full DNVVF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — DNVVF vs EPRT

📍 DNVVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDNVVFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DNVVF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DNVVF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DNVVF
Annual income on $10K today (after 15% tax)
$34,000.00/yr
After 10yr DRIP, annual income (after tax)
$6,517,113,793.10/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, DNVVF beats the other by $6,517,102,878.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DNVVF + EPRT for your $10,000?

DNVVF: 50%EPRT: 50%
100% EPRT50/50100% DNVVF
Portfolio after 10yr
$5718.94M
Annual income
$3,833,602,769.24/yr
Blended yield
67.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

DNVVF
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DNVVF buys
0
EPRT buys
0
No recent congressional trades found for DNVVF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDNVVFEPRT
Forward yield400.00%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$11437.82M$63.4K
Annual income after 10y$7,667,192,697.76$12,840.73
Total dividends collected$11090.87M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: DNVVF vs EPRT ($10,000, DRIP)

YearDNVVF PortfolioDNVVF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$50,700$40,000.00$11,205$505.18+$39.5KDNVVF
2$243,782$189,532.71$12,672$682.46+$231.1KDNVVF
3$1,112,560$851,713.55$14,490$930.48+$1.10MDNVVF
4$4,823,161$3,632,721.39$16,786$1,282.69+$4.81MDNVVF
5$19,879,046$14,718,264.42$19,753$1,791.56+$19.86MDNVVF
6$77,964,520$56,693,940.88$23,677$2,541.64+$77.94MDNVVF
7$291,226,244$207,804,207.46$29,008$3,672.99+$291.20MDNVVF
8$1,037,056,355$725,444,273.70$36,463$5,425.08+$1037.02MDNVVF
9$3,523,955,262$2,414,304,962.28$47,238$8,221.57+$3523.91MDNVVF
10$11,437,824,828$7,667,192,697.76$63,385$12,840.73+$11437.76MDNVVF

DNVVF vs EPRT: Complete Analysis 2026

DNVVFStock

DEINOVE SA, a biotech company, discovers, develops, and produces compounds originating from microbials for the health, nutrition, and cosmetics industries worldwide. The company's antibiotic candidates include DNV3837, an antibiotic, which is in the Phase II clinical trial for the treatment of Clostridioides difficile infections. It also offers PHYT-N-Resist, an anti-aging active ingredient for cosmetics; Luminity, a carotenoid-based ingredient to absorb blue light and exceptional antioxidant properties; HEBELYS, a natural active ingredient produced by fermentation of Sphingomonas; and BIOME Oléoactif, which acts as a post-biotic extract with a prebiotic effect to balance the skin microbiota. In addition, the company develops a process for producing natural ingredients for animal feed. DEINOVE SA has partnership agreements primarily with bioMérieux, Naicons, Medpace, Institut Pasteur, Hallstar Group, Sharon Laboratories, Oléos-Hallstar, Greentech, and Avril. The company was founded in 2006 and is headquartered in Grabels, France.

Full DNVVF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this DNVVF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DNVVF vs SCHDDNVVF vs JEPIDNVVF vs ODNVVF vs KODNVVF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.